Sort
64,565 grants matching “drug discovery”
Structure and Function of Neurotransmitter Transporters
$1,026,736Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2007 · DA
The Cancer Target Discovery and Development Network at UCSF
$1,026,728Michael T McManus · University Of California, San Francisco · U01 · FY2021 · CA
PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA; NIDA REF. NO. N01DA-22-8959. 02/22/2022 - 02/21/2024.
$1,026,528Matthew Walentiny · Virginia Commonwealth University · N01 · FY2023 · DA
ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION
$1,026,410Rockefeller University · R01 · FY2000 · DA
Patient-Derived Models of Prostate Cancer for Personalized Medicine
$1,026,019Nora M Navone · University Of Tx Md Anderson Can Ctr · U01 · FY2021 · CA
SMARTT COORDINATING CENTER
$1,025,933Donald Brambilla · Research Triangle Institute · N01 · FY2011 · HL
An integrated computational and functional genomics discovery engine for preclini
$1,025,918Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA
Biomarker Investigations for Clinical Trials
$1,025,905Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Kidney Microphysiological Analysis Platforms (MAP) to Optimize Function and Model Disease
$1,025,876Joseph Vincent Bonventre · Brigham And Women'S Hospital · UH3 · FY2019 · TR
A genomewide study of lung cancer in never smokers
$1,025,637Olga Gorlova · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
How do genome alterations cause human lung cancer?
$1,025,600Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2015 · CA
Xavier RCMI Renewal Application-Research Infrastructure Core
$1,025,494Vladimir Kolesnichenko · Xavier University Of Louisiana · U54 · FY2021 · MD
Deciphering the physiological role and interplay between ubiquitination and phosphorylation pathways to guide targeted cancer therapies
$1,025,412Wenyi Wei · Beth Israel Deaconess Medical Center · R35 · FY2022 · CA
A Haplotype Map for Multiple Sclerosis
$1,025,276Stephen L Hauser · University Of California, San Francisco · R01 · FY2011 · NS
A molecular toolbox to accelerate drug development for histone lysine methylation regulators
$1,025,085Jonathan Michael Burg · Epicypher, Inc. · R44 · FY2023 · TR
A molecular toolbox to accelerate drug development for histone lysine methylation regulators
$1,025,085Jonathan Michael Burg · Epicypher, Inc. · R44 · FY2022 · TR
Pharmacological Treatment of Retinal Diseases
$1,025,035Krzysztof Palczewski · Case Western Reserve University · R24 · FY2013 · EY
Quantitative mapping of combinatorial histone modifications
$1,024,752Jonathan Michael Burg · Epicypher, Inc. · R44 · FY2022 · HG
Quantitative mapping of combinatorial histone modifications
$1,024,752Jonathan Michael Burg · Epicypher, Inc. · R44 · FY2021 · HG
Development of a chemical reaction sensor array platform for label-free, real-time kinetic analysis of enzyme-substrate reactions to enable high-throughput drug discovery
$1,024,700Bharath Takulapalli · Spoc Proteomics Inc. · R44 · FY2023 · TR
IGF::OT::IGF Medication Discovery Using Rat Models of Relapse; POP 8/29/2014-7/9/2019; FY16 N01DA-14-8917
$1,024,658Patrick Beardsley · Virginia Commonwealth University · N01 · FY2018 · DA
Quantification of combinatorial epigenetic modifications using defined nucleosome standards
$1,024,490Andrea Lynn Johnstone · Epicypher, Inc. · R44 · FY2022 · GM
Quantification of combinatorial epigenetic modifications using defined nucleosome standards
$1,024,490Andrea Lynn Johnstone · Epicypher, Inc. · R44 · FY2023 · GM
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples
$1,024,448Michael-Christopher Keogh · Epicypher, Inc. · R44 · FY2024 · HG
Project 1 - Coronavirus
$1,024,373Mark R Denison · University Of Alabama At Birmingham · U19 · FY2020 · AI